English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Recent clinical management of herpes simplex virus encephalitis (HSVE) is reviewed. The polymerase chain reaction (PCR) in the cerebrospinal fluid (CSF) has been established as a gold standard method. However, several problems for the PCR remain, as follows: the difference of minimum detection sensitivities in PCR, and pseudo-negative result which depend on the day of CSF sample collection after onset. Based on these problems, the diagnostic management of the recent guideline in USA (2008) was revised. Antiviral therapy is highly effective in reducing the mortality rate. However, only less than one-half of patients are able to return to normal. Recent therapeutic managements in EU (2007) and USA recommended acyclovir treatment for 2-3 weeks. However, according to the analysis of prolonged clinical course of HSVE (Taira N et al. 2009), such prolonged acyclovir treatment had a limited potential in their outcome. We recently reported that one pharmacological mechanism related to corticosteroid in HSVE was apparently inhibition of pro-inflammatory cytokines such as IL-6 (Kamei S et al. 2009).

Infection of herpes simplex virus -Clinical diagnosis and treatment for herpes virus encephalitis-